Zobrazeno 1 - 10
of 27
pro vyhledávání: '"hormonska terapija"'
Autor:
Ujević, Boris
Kombinirana hormonska kontracepcija sastoji se od sintetskih i prirodnih estrogena i gestagena. Danas je jedna od najpropisivanijih metoda kontracepcije. Uz kontracepciju postoje brojne medicinske indikacije za koje se kontraceptivi koriste kao terap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::83fba989acc831e707643301268c3935
https://www.bib.irb.hr/1255169
https://www.bib.irb.hr/1255169
Autor:
Đogo, Aleksandar
Publikováno v:
Универзитет у Београду
Menopauza predstavlja period u životu žene, koji počinje godinu dana nakon posljednje menstruacije i traje do kraja života. Karakterisana je opadajućom koncentracijom polnih steroida. Hipoestrogenemija dovodi do porasta krvnog pritiska putem por
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=nardusnacion::6182553d9d09c9baf77944466fe5e8bf
http://nardus.mpn.gov.rs/bitstream/id/148740/DisDjogo.pdf
http://nardus.mpn.gov.rs/bitstream/id/148740/DisDjogo.pdf
Autor:
Dinka Šundov, Branka Petrić-Miše
Publikováno v:
Libri Oncologici, Vol 48, Iss 2-3, Pp 109-115 (2020)
Libri Oncologici : Croatian Journal of Oncology
Volume 48
Issue 2-3
Libri Oncologici : Croatian Journal of Oncology
Volume 48
Issue 2-3
Low-grade serous ovarian cancer (LGSOC) has less aggressive behavior and a better clinical outcome than high-grade serous ovarian cancer (HGSOC). Considering that this malignancy is relatively chemoresistant, surgery is the keystone of treatment, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f78be4c33caf41dfa24516f5545fd9
https://hrcak.srce.hr/file/364268
https://hrcak.srce.hr/file/364268
Autor:
Omrčen, Tomislav
Publikováno v:
Acta clinica Croatica
Volume 61.
Issue Supplement 3
Volume 61.
Issue Supplement 3
For many years, androgen deprivation therapy (ADT) as monotherapy has been the gold standard for metastatic hormone-sensitive prostate cancer (mHSPC) treatment. Several studies have been published within the last decade demonstrating a significant su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf34e455e4edbaf78f35fa9c56c2966
https://doi.org/10.20471/acc.2022.61.s3.12
https://doi.org/10.20471/acc.2022.61.s3.12
Autor:
Petrić-Miše, Branka, Department of Oncology, University Hospital Split and School of Medicine Split, Split, Croatia, Šundov, Dinka
Niskogradusni serozni karcinom jajnika (LGSOC) manje je agresivan i ima bolji klinički ishod u usporedbi s visokogradusnim seroznim karcinomom jajnika (HGSOC). Kirurško liječenje s pokušajem maksimalne citoredukcije važno je i opravdano zbog rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::fc81d598ced6afb41efd53b13b76e428
https://doi.org/10.20471/lo.2020.48.02-03.18
https://doi.org/10.20471/lo.2020.48.02-03.18
Autor:
Pedišić, Mirta
Karcinom prostate u većini razvijenih zemalja za muškarace starije životne dobi predstavlja najčešći oblik karcinoma te drugi uzrok smrti od malignih oboljenja. Kod otkrivanja bolesti bitnu ulogu imaju digitorektalni pregled te antigen specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3b7ddf261dc223b455b98193148751d5
https://urn.nsk.hr/urn:nbn:hr:184:930643
https://urn.nsk.hr/urn:nbn:hr:184:930643
Autor:
Omrčen, Tomislav
Liječenje deprivacijom androgena (ADT ) već dugi niz godina je standardni oblik liječenja bolesnika s metastatskim hormonski osjetljivim rakom prostate (mHSPC). No, nekoliko studija faze 3 potpuno je promijenilo terapijski pristup za ove bolesnike
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::06c2c129474d4d219bcaf7d4dcf242ce
https://www.bib.irb.hr/1156273
https://www.bib.irb.hr/1156273
Autor:
Omrčen, Tomislav
Publikováno v:
Acta clinica Croatica
Volume 58.
Issue Supplement 2
Acta Clinica Croatica
Volume 58.
Issue Supplement 2
Acta Clinica Croatica
Treatment with androgen deprivation (ADT ) has for many years been a standard treatment for patients with metastatic hormone-sensitive prostate cancer (mHSPC). However, several phase 3 randomized trials have completely changed the therapeutic approac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2def8b819bbbe2cded5f004eaff80811
https://hrcak.srce.hr/234292
https://hrcak.srce.hr/234292
Autor:
Čitlučanin, Goran
Publikováno v:
Универзитет у Београду
Uvod. Incidenca KVB kod žena se značajno povećava posle 50. godine a jedan od mogućih krivaca je i menopauza, koju prati pad vrednosti estrogena, što može biti upleteno u razloge brojnih metaboličkih poremećaja. Promena u distribuciji masnog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=nardusnacion::5a367fd69909c21c90fcbc7592afcdce
https://hdl.handle.net/21.15107/rcub_nardus_10567
https://hdl.handle.net/21.15107/rcub_nardus_10567
Autor:
Katarina Antunac
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 46
Issue 2-3
Volume 46
Issue 2-3
Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d66548e5e5331557ad3c79a461d9fa2
https://www.bib.irb.hr/1164729
https://www.bib.irb.hr/1164729